Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Assets" stands at 13.22 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Amgen Inc's third quarter, the item "Other Long Term Assets" stands at 13.22 Billion USD. This represents an increase of 19.97 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.84 Billion United States Dollars compared to the value the year prior.
The 1 year change is 2.84 Billion United States Dollars.
The 3 year change is 6.88 Billion United States Dollars.
The 5 year change is 7.99 Billion United States Dollars.
The 10 year change is 11.47 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |